Comparing Blood Vessel Endothelial Function in HIV-Infected People and Matched HIV-Uninfected People

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Samir K Gupta, MD, MS, National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00919724
First received: June 11, 2009
Last updated: July 1, 2014
Last verified: July 2014
Results First Received: May 28, 2014  
Study Type: Observational
Study Design: Observational Model: Case Control;   Time Perspective: Prospective
Condition: HIV Infection

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
HIV-Infected HIV-infected participants who are not currently receiving antiretroviral medications
HIV-Uninfected HIV-uninfected participants matched in age, sex, smoking status, and height to the HIV-infected participants

Participant Flow:   Overall Study
    HIV-Infected     HIV-Uninfected  
STARTED     45     44  
COMPLETED     45     44  
NOT COMPLETED     0     0  



  Baseline Characteristics


  Outcome Measures

1.  Primary:   Endothelial Function (Brachial Artery Reactivity)   [ Time Frame: Single measurement ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Results Point of Contact:  
Name/Title: Samir K. Gupta, MD, MS
Organization: Indiana University School of Medicine
phone: 317-274-7926
e-mail: sgupta1@iu.edu


No publications provided


Responsible Party: Samir K Gupta, MD, MS, National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT00919724     History of Changes
Other Study ID Numbers: 661, R01HL095149, HL095149
Study First Received: June 11, 2009
Results First Received: May 28, 2014
Last Updated: July 1, 2014
Health Authority: United States: Federal Government